SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384
http://www.w3.org/2000/01/rdf-schema#comment
"Drugs targeting XIAP and cIAP1/2 may be effective for osteosarcoma patients whose tumors express abundant RIPK1 and contain high levels of TNFalpha."
xsd:string
http://purl.uniprot.org/uniprot/#_2E770BFF8F8C59A449D99755F8FB68062AD7861A3C91387CDC17C707B4D907B72E91082533ACD608F46E0633D033FB3E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384
http://purl.uniprot.org/uniprot/Q60989
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384
http://purl.uniprot.org/uniprot/#_Q60989-mappedCitation-27129149
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/4365137AAF8C7E452C2A394DD3198978E7508E35008E4527B10630283AC84160B3E2425028AF3907CD5C40F106FF1384